RT Journal Article
SR Electronic
T1 How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis?
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.190211
DO 10.3899/jrheum.190211
A1 Kulveer Mankia
A1 Christopher Briggs
A1 Paul Emery
YR 2019
UL http://www.jrheum.org/content/early/2019/11/25/jrheum.190211.abstract
AB Early referral and initiation of disease-modifying antirheumatic drugs (DMARD) is associated with better outcomes for patients with rheumatoid arthritis (RA)1,2. In the United Kingdom, general practitioners (GP) are advised to refer patients with suspected RA urgently3 and rheumatology departments are rewarded for timely management of these patients4.